We are live on ! Find out more
WEC

Winslow Evans & Crocker Portfolio holdings

AUM $528M
1-Year Est. Return 30.99%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
+30.99%
3 Year Est. Return
+76.2%
5 Year Est. Return
+147.26%
10 Year Est. Return
–
AUM
$365M
AUM Growth
+$46.1M
Cap. Flow
+$37.6M
Cap. Flow %
10.3%
Top 10 Hldgs %
19.35%
Holding
1,326
New
84
Increased
304
Reduced
473
Closed
56

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.28M
2
ADP icon
Automatic Data Processing
ADP
+$2.29M
3
AMZN icon
Amazon
AMZN
+$1.57M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.47M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$1.22M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$3.44M
2
ORCL icon
Oracle
ORCL
+$1.05M
3
ETP
Energy Transfer Partners L.p.
ETP
+$657K
4
HDB icon
HDFC Bank
HDB
+$522K
5
BA icon
Boeing
BA
+$473K

Sector Composition

Rank Sector Weight
1 Technology 19.43%
2 Healthcare 11.88%
3 Financials 10.98%
4 Consumer Discretionary 8.56%
5 Energy 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MGF
1226
Aberdeen Government Markets Income Fund
MGF
$91.6M
$651 ﹤0.01%
130
-58
-31% -$288
UA icon
1227
Under Armour Class C
UA
$2.92B
$645 ﹤0.01%
32
– –
RGT
1228
Royce Global Value Trust
RGT
$95.8M
$634 ﹤0.01%
66
– –
RCI icon
1229
Rogers Communications
RCI
$17.7B
$614 ﹤0.01%
13
-1
-7% -$46
WIA
1230
Western Asset Inflation-Linked Income Fund
WIA
$185M
$565 ﹤0.01%
50
– –
SMFG icon
1231
Sumitomo Mitsui Financial
SMFG
$166B
$558 ﹤0.01%
71
-1
-1% -$7
TIME
1232
DELISTED
Time Inc.
TIME
$545 ﹤0.01%
38
– –
GCVRZ
1233
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$538 ﹤0.01%
1,416
– –
UBS icon
1234
UBS Group
UBS
$170B
$509 ﹤0.01%
30
– –
RRD
1235
DELISTED
RR Donnelley & Sons Co.
RRD
$489 ﹤0.01%
39
-1
-3% -$12
EGY icon
1236
Vaalco Energy
EGY
$594M
$468 ﹤0.01%
500
– –
EGL
1237
DELISTED
Engility Holdings, Inc.
EGL
$454 ﹤0.01%
16
– –
ALSK
1238
DELISTED
Alaska Communications Systems
ALSK
$440 ﹤0.01%
200
– –
PBR icon
1239
Petrobras
PBR
$121B
$431 ﹤0.01%
54
– –
JAX
1240
DELISTED
J. Alexander's Holdings, Inc.
JAX
$429 ﹤0.01%
35
-1
-3% -$11
VRTV
1241
DELISTED
VERITIV CORPORATION
VRTV
$405 ﹤0.01%
9
-1
-10% -$46
ANIP icon
1242
ANI Pharmaceuticals
ANIP
$1.77B
$374 ﹤0.01%
8
– –
VVX icon
1243
V2X
VVX
$2.62B
$356 ﹤0.01%
11
-1
-8% -$28
CEO
1244
DELISTED
CNOOC Limited
CEO
$328 ﹤0.01%
3
-1
-25% -$115
DFIN icon
1245
Donnelley Financial Solutions
DFIN
$1.21B
$321 ﹤0.01%
14
– –
LKSD
1246
DELISTED
LSC Communications, Inc.
LKSD
$300 ﹤0.01%
14
– –
ING icon
1247
ING
ING
$93.8B
$296 ﹤0.01%
17
-89
-84% -$1.46K
MVO
1248
MV Oil Trust
MVO
$6.85M
$291 ﹤0.01%
50
– –
CHU
1249
DELISTED
China Unicom (HONG KONG) Limited
CHU
$269 ﹤0.01%
18
– –
ASIX icon
1250
AdvanSix
ASIX
$567M
$250 ﹤0.01%
8
-2
-20% -$57
48 49
50
51 52

Similar funds

PJB
Paul John Balson Marina Del Rey, California $486M AUM 78.12% 1-Year Est. Return
IVA
International Value Advisers $615M AUM 6.37% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
PSSGI
P-STS SPV GP IA San Francisco, California $433M AUM
AVAX
Atlas Venture Associates XI Cambridge, Massachusetts $631M AUM
DK
Darrell & King Charlottesville, Virginia $633M AUM 49.4% 1-Year Est. Return
MCM
Matarin Capital Management New York $409M AUM 33.03% 1-Year Est. Return
GBBWRPM
Genovese Burford & Brothers Wealth & Retirement Plan Management Sacramento, California $400M AUM 14.87% 1-Year Est. Return

Winslow Evans & Crocker's Q2 2017 Portfolio in Review

As of Q2 2017, Winslow Evans & Crocker held 1,326 positions worth $365M, up 14% from $318M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Winslow Evans & Crocker deployed $37.6M of net new capital in Q2 2017, opening 84 new positions and adding to 304 existing holdings. Its largest new stake was Idexx Laboratories: 3,900 shares worth $629K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Allergan plc, an estimated $3.44M trimmed.

  • Winslow Evans & Crocker's largest Q2 2017 buy was Idexx Laboratories: 3,900 shares worth $629K.
  • Winslow Evans & Crocker added most to Microsoft in Q2 2017, an estimated $3.28M increase.
  • Winslow Evans & Crocker's biggest Q2 2017 reduction was Allergan plc, cutting an estimated $3.44M.
  • Winslow Evans & Crocker fully exited State Street Energy Select Sector SPDR ETF in Q2 2017, selling an estimated $428K.
  • Winslow Evans & Crocker's ten largest holdings make up 19% of its $365M portfolio in Q2 2017.
  • Winslow Evans & Crocker opened 84 new positions and closed 56 in Q2 2017.
  • Winslow Evans & Crocker's portfolio value rose 14% quarter-over-quarter to $365M.

Based on Winslow Evans & Crocker's 13F filing for Q2 2017, filed 14 Jul 2017.